MD Anderson applauds FDA approval of HPV vaccine

The Food and Drug Administration's (FDA) approval of a new vaccine that targets five additional strains of human papilloma virus (HPV) fortifies a proven cancer-prevention weapon, according to Ronald A. DePinho, M.D., president of The University of Texas MD Anderson Cancer Center. 
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news